The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-[3-(3-Phenoxyphenyl)propyl]phosphonomalonamide Potassium Salt ID: ALA523897
PubChem CID: 44185451
Max Phase: Preclinical
Molecular Formula: C18H18KNO4
Molecular Weight: 313.35
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C([O-])CC(=O)NCCCc1cccc(Oc2ccccc2)c1.[K+]
Standard InChI: InChI=1S/C18H19NO4.K/c20-17(13-18(21)22)19-11-5-7-14-6-4-10-16(12-14)23-15-8-2-1-3-9-15;/h1-4,6,8-10,12H,5,7,11,13H2,(H,19,20)(H,21,22);/q;+1/p-1
Standard InChI Key: WMMPEDWPOKDWRL-UHFFFAOYSA-M
Molfile:
RDKit 2D
24 24 0 0 0 0 0 0 0 0999 V2000
18.3611 -26.0704 0.0000 K 0 0 0 0 0 15 0 0 0 0 0 0
9.8908 -25.6971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8922 -26.5208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6079 -26.9297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3214 -26.5137 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3145 -25.6844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5983 -25.2792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0256 -25.2658 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7435 -25.6723 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4544 -25.2537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1724 -25.6602 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.8833 -25.2416 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6013 -25.6481 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8764 -24.4166 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.3122 -25.2295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0302 -25.6359 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.3053 -24.4045 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.1739 -25.2888 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.4619 -25.7055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7473 -25.2943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0357 -25.7103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0401 -26.5362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7619 -26.9443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4706 -26.5260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12 13 1 0
6 7 2 0
12 14 2 0
7 2 1 0
13 15 1 0
3 4 1 0
15 16 2 0
6 8 1 0
15 17 1 0
2 18 1 0
8 9 1 0
18 19 1 0
4 5 2 0
19 20 2 0
9 10 1 0
20 21 1 0
2 3 2 0
21 22 2 0
10 11 1 0
22 23 1 0
5 6 1 0
23 24 2 0
24 19 1 0
11 12 1 0
M CHG 2 1 1 17 -1
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 313.35Molecular Weight (Monoisotopic): 313.1314AlogP: 3.00#Rotatable Bonds: 8Polar Surface Area: 75.63Molecular Species: ACIDHBA: 3HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.85CX Basic pKa: ┄CX LogP: 3.04CX LogD: -0.20Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.58Np Likeness Score: -0.44
References 1. Song Y, Liu CI, Lin FY, No JH, Hensler M, Liu YL, Jeng WY, Low J, Liu GY, Nizet V, Wang AH, Oldfield E.. (2009) Inhibition of staphyloxanthin virulence factor biosynthesis in Staphylococcus aureus: in vitro, in vivo, and crystallographic results., 52 (13): [PMID:19456099 ] [10.1021/jm9001764 ]